Home | Screening data | Screen comparisons | Search for compounds | Structure search

Compound InformationSONAR Target prediction
Name:

Meclofenamic acid sodium salt monohydrate

Unique Identifier:Prest829
MolClass: Checkout models in ver1.5 and ver1.0
Molecular Formula:C14Cl2H12NNaO3
Molecular Weight:324.05 g/mol
X log p:13.048  (online calculus)
Lipinksi Failures1
TPSA40.13
Hydrogen Bond Donor Count:0
Hydrogen Bond Acceptors Count:3
Rotatable Bond Count:3
Canonical Smiles:O.[Na+].[O-]C(=O)c1ccccc1Nc1c(Cl)ccc(C)c1Cl
Generic_name:Meclofenamate
Chemical_iupac_name:2-[(2,6-dichloro-3-methyl-phenyl)amino]benzoic acid
Drug_type:Approved Drug
Pharmgkb_id:PA450341
Kegg_compound_id:C02996
Drugbank_id:APRD01090
Melting_point:257 oC
H2o_solubility:30 mg/L
Logp:4.998
Cas_registry_number:644-62-2
Drug_category:Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; ATC:M01AG04;
ATC:M02AA18
Indication:For the relief of mild to moderate pain, for the treatment of primary dysmenorrhea
and for the treatment of idiopathic heavy menstrual blood loss. Also for relief of
the signs and symptoms of acute and chronic rheumatoid arthritis and osteoarthritis.
Pharmacology:Meclofenamate is a nonsteroidal agent which has demonstrated anti-inflammatory,
analgesic, and antipyretic activity in laboratory animals.
Mechanism_of_action:The mode of action, like that of other nonsteroidal anti-inflammatory agents, is not
known. Therapeutic action does not result from pituitary-adrenal stimulation. In
animal studies, meclofenamate was found to inhibit prostaglandin synthesis and to
compete for binding at the prostaglandin receptor site. In vitro meclofenamate was
found to be an inhibitor of human leukocyte 5-lipoxygenase activity. These
properties may be responsible for the anti-inflammatory action of meclofenamate.
There is no evidence that meclofenamate sodium alters the course of the underlying
disease.
Organisms_affected:Humans and other mammals

Found: 3 nonactive as graph: single | with analogs << Back 1 2 3 Next >> 
Species: 9606
Condition: TMPPre002
Replicates: 2
Raw OD Value: r im 9293.0000±0
Normalized OD Score: sc h 0.9124±0
Z-Score: -1.9753±0
p-Value: 0.0482372
Z-Factor: -234.242
Fitness Defect: 3.0316
Bioactivity Statement: Nonactive
Experimental Conditions
Library:Prestwick
Plate Number and Position:3|E7
Drug Concentration:50.00 nM
OD Absorbance:0 nm
Robot Temperature:23.60 Celcius
Date:2006-10-10 YYYY-MM-DD
Plate CH Control (+):1037.5±978.23463
Plate DMSO Control (-):2014±552.18250
Plate Z-Factor:-4.9321
png
ps
pdf

DBLink | Rows returned: 5
4036 2-[(2,6-dichloro-3-methyl-phenyl)amino]benzoate
4037 2-[(2,6-dichloro-3-methyl-phenyl)amino]benzoic acid
4038 sodium 2-[(2,6-dichloro-3-methyl-phenyl)amino]benzoate
22881 sodium 2-[(2,6-dichloro-3-methyl-phenyl)amino]benzoate
5282369 sodium 2-[(2,6-dichloro-3-methyl-phenyl)amino]benzoate hydrate

internal high similarity DBLink | Rows returned: 0

active | Cluster 15311 | Additional Members: 3 | Rows returned: 2
LOPAC 01048 0
SPE01500377 0

Service provided by the Mike Tyers Laboratory